P-SMAD3, a marker of constitutive TGF-β receptor activity, was detected in all melanoma cell lines that we examined, not in normal melanocytes, consistent with our initial observations of autocrine SMAD signaling in various human melanoma cell lines in culture [35]. Here, SMAD3 is linked to melanoma.